In human SH-SY5Y neuroblastoma cells transfected with wild-type APP, TSPO ligand treatment (10 nM, 24 h) including two TSPO ligands of reference XDB173 and SSR-180,575 and two new imidazoquinazolinone compounds exerted neuroprotective effects. The gene discussed is TSPO; the disease is neuroblastoma.